staging moments head neck 1

Upload: isabel

Post on 02-Jun-2018

221 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/11/2019 Staging Moments Head Neck 1

    1/22

    AJCC Staging Moments

    AJCC TNM Staging 7th Edition

    Glottic Larynx Case #1

    Contributors:Jatin P. Shah, MD Memorial Sloan-Kettering Cancer Center, New York, New YorkCarol R. Bradford, MD University of Michigan Medical Center, Ann Arbor, Michigan

    James Brierley, MB Princess Margaret Hospital/University Health Network, Toronto, Ontario

  • 8/11/2019 Staging Moments Head Neck 1

    2/22

    Larynx Case # 1Presentation of New Case

    Newly diagnosed larynx cancer patient

    Presentation at Cancer Conference for treatmentrecommendations and clinical staging

  • 8/11/2019 Staging Moments Head Neck 1

    3/22

    Larynx Case # 1History & Physical

    63 yr old female who presented with a raspyvoice, no palpable lymphadenopathy

    No smoking hx

    No family history of ca

  • 8/11/2019 Staging Moments Head Neck 1

    4/22

  • 8/11/2019 Staging Moments Head Neck 1

    5/22

    Larynx Case # 1Diagnostic Procedure

    Procedure Biopsy left vocal cord during laryngoscopy with

    operating microscope

    Pathology Report Well differentiated squamous cell ca Grade 1

    HPV status is negative

  • 8/11/2019 Staging Moments Head Neck 1

    6/22

    Larynx Case # 1Clinical Staging

    Clinical staging Uses information from the physical exam, imaging,

    and diagnostic biopsy

    Purpose Select appropriate treatment Estimate prognosis

  • 8/11/2019 Staging Moments Head Neck 1

    7/22

    Larynx Case # 1Clinical Staging

    Synopsis- patient with small lesion on left vocalcord, clinically negative lymph nodes

    What is the clinical stage? T____ N____

    M____ Stage Group______

  • 8/11/2019 Staging Moments Head Neck 1

    8/22

    Larynx Case # 1Clinical Staging

    Clinical Stage correct answer T1a N0 M0 Stage Group I

    Based on stage and other factors, treatment isselected

    Review NCCN treatment guidelines for this stage

  • 8/11/2019 Staging Moments Head Neck 1

    9/22

  • 8/11/2019 Staging Moments Head Neck 1

    10/22

    Prognostic FactorsClinically Significant

    Applicable to this case

    Human papillomavirus (HPV) status: neg

    HPV is less prevalent in laryngeal cancer thanoropharyngeal cancers

    There are no prognostic factors required forstaging

  • 8/11/2019 Staging Moments Head Neck 1

    11/22

  • 8/11/2019 Staging Moments Head Neck 1

    12/22

    Larynx Case # 1Presentation after Surgery

    The choice of treatment lies between Definitive external beam radiotherapy Endoscopic laser resection Open partial laryngectomy

    The procedure chosen based on patient factors and thelesion confined to one vocal cord and clinically negativenodes, Stage I, is partial laryngectomy

    Presentation at Cancer Conference for adjuvanttreatment recommendations and pathologic staging

  • 8/11/2019 Staging Moments Head Neck 1

    13/22

    Larynx Case # 1Surgery & Findings

    Procedure Partial laryngectomy

    Operative findings No additional information

  • 8/11/2019 Staging Moments Head Neck 1

    14/22

    Larynx Case # 1Pathology Results

    Squamous cell carcinoma, involving lt vocal cord Tumor size - 1.2cm Grade - moderately differentiated Maximal thickness - 0.7cm Invades lamina propria Extension to anterior commissure Margins negative 4 regional nodes negative

  • 8/11/2019 Staging Moments Head Neck 1

    15/22

    Larynx Case # 1Pathologic Staging

    Pathologic staging Uses information from the clinical staging

    supplemented or modified by information from

    surgery and the pathology report

    Purpose Additional precise data for estimating prognosis Calculating end results (survival data)

  • 8/11/2019 Staging Moments Head Neck 1

    16/22

    Larynx Case # 1Pathologic Staging

    Synopsis- patient with 1.2cm lt vocal cord lesionextending to the anterior commissure, regionalnodes negative

    What is the pathologic stage?(remember, clinical M may be used in pathologic staging)

    T____

    N____ M____ Stage Group______

  • 8/11/2019 Staging Moments Head Neck 1

    17/22

    Larynx Case # 1Pathologic Staging

    Pathologic Stage correct answer pT1a pN0 cM0 Stage Group I

    Based on pathologic stage, there is moreinformation to estimate prognosis and forselection of adjuvant treatment.

  • 8/11/2019 Staging Moments Head Neck 1

    18/22

    Larynx Case # 1Pathologic Staging

    Rationale for staging choices pT1a for tumor limited to one vocal cord (may involve

    anterior or posterior commissure) with normal mobility

    pN0 because regional nodes were negative

    cM0 - use clinical M with pathologic staging unlessthere is pathologic confirmation of distant metastases

  • 8/11/2019 Staging Moments Head Neck 1

    19/22

    Prognostic FactorsClinically Significant

    Applicable to this case

    Size of lymph nodes: n/a

    Extracapsular extension from lymph nodes: n/a

    Lymph node levels involved: n/a

    Extracapsular spread (ECS) pathologic: n/a

    Human papillomavirus (HPV) status: neg

    There are no prognostic factors required for staging

  • 8/11/2019 Staging Moments Head Neck 1

    20/22

    AJCC Cancer Staging AtlasT1 limited to vocal cord(s),

    normal mobility

    T1a one vocal cord

    T1b both vocal cords

  • 8/11/2019 Staging Moments Head Neck 1

    21/22

    Larynx Case # 1Recap of Staging

    Summary of correct answers Clinical stage T1a N0 M0 Stage Group I Pathologic stage T1a N0 cM0 Stage Group I

    The staging classifications have a different purposeand therefore can be different. Do not go back and

    change the clinical staging based on pathologicstaging information.

  • 8/11/2019 Staging Moments Head Neck 1

    22/22

    Staging Moments Summary

    Review site-specific information if needed Clinical Staging

    Based on information before treatment Used to select treatment options

    Pathologic Staging Based on clinical data PLUS surgery and pathology

    report information Used for selection of adjuvant treatment and prognosis Used to evaluate end-results (survival)